Procaps Group S.A. (NASDAQ:PROC – Get Free Report) shares dropped 5.9% during trading on Friday . The company traded as low as $1.92 and last traded at $1.92. Approximately 861 shares changed hands during trading, a decline of 93% from the average daily volume of 12,104 shares. The stock had previously closed at $2.04.
Procaps Group Trading Down 5.9 %
The stock has a market cap of $216.61 million, a price-to-earnings ratio of 3.69 and a beta of 0.16. The firm’s 50 day moving average is $1.99 and its two-hundred day moving average is $2.39.
Procaps Group Company Profile
Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.
Featured Articles
- Five stocks we like better than Procaps Group
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Is Spotify Stock Poised to Soar? Options Traders Think So
- Technology Stocks Explained: Here’s What to Know About Tech
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
Receive News & Ratings for Procaps Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procaps Group and related companies with MarketBeat.com's FREE daily email newsletter.
